Guanylate cyclase C as a target for prevention, detection, and therapy in colorectal cancer.
about
Current Status and Perspectives Regarding LNA-Anti-miR Oligonucleotides and microRNA miR-21 Inhibitors as a Potential Therapeutic Option in Treatment of Colorectal Cancer.Meeting report of the 8th International Conference on cGMP "cGMP: generators, effectors, and therapeutic implications" at Bamberg, Germany, from June 23 to 25, 2017.Human GUCY2C-Targeted Chimeric Antigen Receptor (CAR)-Expressing T Cells Eliminate Colorectal Cancer Metastases
P2860
Guanylate cyclase C as a target for prevention, detection, and therapy in colorectal cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Guanylate cyclase C as a targe ...... therapy in colorectal cancer.
@en
Guanylate cyclase C as a targe ...... therapy in colorectal cancer.
@nl
type
label
Guanylate cyclase C as a targe ...... therapy in colorectal cancer.
@en
Guanylate cyclase C as a targe ...... therapy in colorectal cancer.
@nl
prefLabel
Guanylate cyclase C as a targe ...... therapy in colorectal cancer.
@en
Guanylate cyclase C as a targe ...... therapy in colorectal cancer.
@nl
P2093
P2860
P1476
Guanylate cyclase C as a targe ...... therapy in colorectal cancer.
@en
P2093
Allison A Aka
Amanda M Pattison
Jeff A Rappaport
Takami Sato
P2860
P304
P356
10.1080/17512433.2017.1292124
P407
P577
2017-02-04T00:00:00Z